Introduction
Polyphenols are secondary plant products that occur ubiquitously in food plants (Hertog et al, 1992) . The two major classes, flavonoids and phenolic acids, exert strong antioxidant effects in vitro (Rice-Evans et al, 1996) and can elevate the plasma antioxidant capacity in humans in vivo (Whitehead et al, 1995; Serafini et al, 1996; Carbonneau et al, 1997; Day et al, 1997) . Several epidemiologic studies suggest protective effects of polyphenols against coronary heart disease ( Hertog, 1996) and cancer (Blot et al, 1996; Kuo, 1997) that might be attributed to their antioxidant properties.
In HIV-infected individuals, oxidative stress is widespread even in the early asymptomatic stages (Eck et al, 1989; Pace & Leaf, 1995) . This fact is due to an insufficient supply of antioxidants because of gastrointestinal disorders (Baum et al, 1992; Pace & Leaf, 1995) and an increased production of reactive oxygen species by the chronically activated immune system (Roederer et al, 1992; Israel & Gougerot-Pocidalo, 1997) . Oxidative stress might influence disease progression because it contributes to viral activation and replication as well as CD4 þ cell depletion (Baruchel & Wainberg, 1992; Pace & Leaf, 1995; Israel & Gougerot-Pocidalo, 1997) . The supplementation of antioxidants might counteract oxidative stress and improve immune function in HIV-infected patients (Coodley et al, 1993; Greenspan & Aruoma, 1994; Allard et al, 1998) . In this study we investigated the effects of polyphenol supplementation either via fruit juices or a fruit -vegetableconcentrate on the antioxidant capacity in plasma of HIVinfected patients and healthy subjects.
Subjects and methods

Study design
In a preliminary study we investigated the kinetic effects of a single ingestion of fruit juice or fruit -vegetable-concentrate on plasma antioxidant capacity in healthy volunteers.
Subsequently the long-term effects of polyphenol supplementation on plasma antioxidant capacity were studied in a clinical trial in HIV-infected and healthy subjects. All participants had given their informed consent. The study was performed according to the guidelines of the Declaration of Helsinki and its revisions and was approved by the ethics committee of the University of Bonn.
Kinetic study
Sixteen HIV-seronegative non-smokers were randomly allocated to receive a single dose of either 1 l of blackcurrant juice (Eckes Granini GmbH, Nieder-Olm, Germany, group A) or 30 ml of a fruit -vegetable-concentrate (Cellagon aurum 1 , H.G. Berner GmbH, Altenholz, Germany, group B) to study short-term TEAC kinetics after administration of these polyphenol-rich drinks. The median age of group A (six female (f ), three male (m)) was 29 y (range 26 -36 y), the average body mass index (BMI) was 22.6 AE 2.3 kg=m 2 . Three women and four men were allocated to group B. Their median age was 35 y (26 -46 y) and their average BMI was 23.1 AE 1.9 kg=m 2 . None of the 16 volunteers used any micronutrient supplements.
The antioxidant capacity in plasma was measured before and 30, 60, 90, 120 and 300 min after ingestion of either fruit juice or fruit -vegetable-concentrate.
Clinical trial
Twenty-three HIV-seropositive subjects (4 f, 19 m) at different disease stages (see Table 1 ) and 18 HIV-seronegative subjects (8 f, 10 m) volunteered in a 16 week intervention trial. The participants were randomized to receive either 1 l of fruit juice (group J) or 30 ml of a fruit -vegetable-concentrate (group C) for 16 weeks in addition to their usual Western diet.
Demographic and medical data are summarized in Table  1 . The antioxidant capacity in plasma was determined at baseline, after 1 and 16 weeks of intervention, and after a subsequent washout period of 6 weeks.
At the first visit the HIV serostatus was checked by a sandwich-ELISA (AXSYM-System, Abbott, Mainz, Germany). Furthermore the CD4 þ cell count, the HIV viral load, plasma concentrations of total protein, cholesterol, HDL, LDL, triacylglycerols, urate and bilirubin were determined by routine procedures in the central clinical lab.
Twenty of 23 HIV patients could be evaluated statistically (see below). Of these, 16 patients (80%) received antiretroviral drug therapy. Eight of them received a triple therapy consisting of two nucleoside reverse transcriptase inhibitors (NRTI) and one protease inhibitor (PI). One patient took one NRTI only and three patients used two NRTI. Two subjects took one NRTI and one PI.
Combinations of one NRTI þ two PI or two NRTI þ two PI, respectively, were given in one case each. Four subjects among the patients with antiretroviral therapy changed their treatment during the course of the trial. One patient each switched from two NRTI to one NRTI þ one PI, from two NRTI þ one PI to one NRTI þ one PI or from two Plasma antioxidant capacity BM Arendt et al NRTI þ two PI to two NRTI þ one PI þ one non-nucleoside reverse transcriptase inhibitor (NNRTI), respectively. One subject receiving one NRTI þ two PI during the first 2 months switched therapy three times within the observation period. One patient taking one NRTI þ one PI in the beginning stopped antiretroviral therapy during the washout period.
Smoking and the intake of additional supplements (minerals, vitamins or protein) are very common in HIVinfected subjects and therefore were allowed, but had to be recorded (Table 1) .
The subjects in group J ingested 1 l of fruit juice daily. They could choose between five types of juice (blackcurrant, apple, red grape, pear and green tea -apple drink, all from Eckes Granini GmbH, Nieder-Olm, Germany). The average proportion of juices chosen was 24% blackcurrant juice, 22% apple juice, 21% red grape juice, 18% pear juice and 14% green tea -apple drink. The participants in group C received 30 ml of the fruit -vegetable-concentrate per day. As quercetin is the major flavonoid in foodstuff (Hertog et al, 1992) , its concentration was used as a marker for the total polyphenol contents of the beverages. The additional daily intake of quercetin and antioxidant vitamins from juices or concentrate is given in Table 2 .
Dietary intake of antioxidants
The composition of the baseline diet was assessed by selfcompleted 1-week food questionnaires, conducted before polyphenol supplementation and during week 16 of the intervention. Food records were analyzed using NutriGuide plus (Version 1.20, BLS II 1994; Nutri-Science GmbH, Umschau-Verlag, Frankfurt=Main, Germany). Quercetin intake was calculated according to Linseisen et al (1997) .
Collection and preparation of plasma samples
Venous blood samples were drawn between 8:00 and 11:00 am. All samples were collected in lithium -heparin tubes and centrifuged for 10 min at 800 g at room temperature. Plasma was stored at 770 C for 2 months until analyzed.
The subjects were instructed not to drink any fruit juices or concentrate in the morning before blood drawing and to record what they had had for breakfast.
Antioxidant capacity
A modified trolox equivalent antioxidant capacity (TEAC) assay (Miller et al, 1993) was used to determine the antioxidant potential in plasma. Hydrogen peroxide and metmyoglobin induce the oxidation of 2,2 0 -azinobis-(3-ethylbenzthiazoline-6-sulfonate; ABTS; Aldrich, Deisenhofen, Germany) to form the stable radical cation ABTS þ . The absorption of the bluish-green color of ABTS þ is measured photometrically. Antioxidants delay the formation of ABTS þ . The percentage of inhibition compared to the blank is proportional to the antioxidant activity of the substance under investigation. The antioxidant capacity is given in comparison to a 1 mM Trolox standard solution (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid), a water-soluble vitamin E analog (Aldrich).
Metmyoglobin was prepared from myoglobin as described by Miller et al (1993) . Phosphate-buffered saline (PBS), sodium chloride, myoglobin, potassium ferricyanide, sephadex G-15, and hydrogen peroxide were purchased from Sigma (Deisenhofen, Germany). The concentration of the working solutions were 188 mM ABTS (in PBS), 90 mM metmyoglobin (in PBS) and 90 mM H 2 O 2 (in aqua bidest). For analysis, the solutions were used at 24 C. Aliquots of 1200 ml ABTS, 50 ml metmyoglobin and 15 ml standard solution, sample or buffer for the blank, respectively, were mixed and incubated in the dark at room temperature for 15 min. The addition of 300 ml H 2 O 2 started the reaction. The absorbance was measured at 734 nm. The assay had to be modified to account for the sensitivity of the method against changes of room temperature. Thus, the reading was not fixed at 6 min but started when the blank reached an absorbance (Abs) of 0.5 which took 5 -7 min. The inhibition of the samples was calculated in relation to the blank: inhibition % ¼ (Abs blanblank 7Abs sample )=Abs blank . A Trolox standard curve was applied to calculate the TEAC. All samples were determined as triplicates. The TEAC assay showed an intraassay variance <2%, and an interassay variance <4.5%.
Statistical analyses
Values given are means AE s.d. unless indicated otherwise. Differences between the intervention groups at baseline were examined using the Mann -Whitney U-test for all parameters. TEAC values within the groups during the observation period were compared using the Wilcoxon signed rank test. ANOVA and Fisher's procedure of least square differences were performed to examine the influence of HIV-serostatus, source and time of polyphenol supplementation, gender and smoking habits on plasma antioxidant capacity.
Regression analyses were used to examine correlations between TEAC and biochemical parameters. Differ- Based on the mean daily intake of 242 ml blackcurrant juice, 223 ml apple juice, 213 ml red grape juice, 183 ml pear juice and 138 ml green tea -apple drink. According to a selfcompleted one-week food-questionnaire taken before polyphenol supplementation. Intake exclusively from foodstuff. Vitamin and mineral preparations are not included. 
Results
TEAC kinetics after single dose polyphenol application
The plasma antioxidant capacity at baseline was not statistically different between the subjects receiving juice or concentrate (P ¼ 0.8). The ingestion of 1 l blackcurrant juice as well as 30 ml fruit -vegetable-concentrate led to an increase of plasma TEAC (Figure 1 ). With both kinds of supplementation the maximum was reached after 60 min.
The maximum increase was from 1.31 AE 0.10 to 1.34 AE 0.08 mM (P ¼ 0.05) after administration of blackcurrant juice. The mean relative change was þ 2.39 AE 2.89%. In subjects taking the concentrate the plasma TEAC increased from 1.33 AE 0.07 to 1.36 AE 0.06 mM (P ¼ 0.04), corresponding to an average change of þ 2.25 AE 1.98%. Thereafter TEAC decreased and reached baseline levels at 300 min.
Clinical intervention trial by polyphenol supplementation
During the trial four subjects were lost to follow up (one HIV-seropositive patient allocated to group J, two HIVseropositive subjects and one healthy control allocated to group C). The macronutrient food composition in both HIV-positive and -negative subjects was the average Western diet. The dietary intake (exclusively from foodstuff) of antioxidants at baseline was not statistically different between the treatment groups (P > 0.1). Although intake of vitamin preparations was only reported in HIV-infected subjects, the total intake (food þ vitamin preparations) of quercetin, vitamin C, vitamin E, and b-carotene did not differ between HIV-infected and healthy subjects (P > 0.09). The dietary and total intake of vitamin C and E and b-carotene was higher in group C than in group J during intervention (P 0.00001). Daily intake of quercetin, vitamin C, vitamin E and b-carotene before and during intervention is shown in Figure 2 . At baseline plasma antioxidant capacity was not statistically different between healthy controls and HIV-infected patients (1.35 AE 0.09 vs 1.39 AE 0.07 mM; P ¼ 0.1). After 16 weeks of intervention the TEAC was increased as compared to baseline in HIV-infected patients (group J P ¼ 0.034; group C, P ¼ 0.025) but not in healthy subjects (group J, P ¼ 0.1; group C, P ¼ 1.0). Table 3 shows the plasma TEAC values found in the different groups before, during and after supplementation of juices or concentrate.
At baseline there were no correlations between the plasma TEAC and BMI, triacylglycerols, cholesterol, CD4 þ cell counts, or viral load, respectively. However, baseline TEAC was positively correlated with the concentrations of total protein (r ¼ 0.59; P<0.0001), bilirubin (r ¼ 0.43; P ¼ 0.02) and urate (r ¼ 0.51; P ¼ 0.0002), which are important antioxidants in plasma.
As smoking is an important source of free radicals and thus influencing the plasma antioxidant capacity, the data of smokers and non-smokers were considered separately. Figure 3 shows the changes of plasma TEAC during polyphenol supplementation in HIV-infected and healthy smokers and non-smokers.
Possible influence of gender on baseline TEAC was investigated in the pooled cohort of healthy non-smokers of the kinetic and the intervention study. There was no difference of plasma TEAC before polyphenol supplementation between women (n ¼ 12) and men (n ¼ 15) (1.32 AE 0.09 vs 1.38 AE 0.08 mM; P ¼ 0.09). 
Discussion
Enhanced oxidative stress and decreased antioxidant micronutrient concentrations have been documented in HIVinfected populations (Pace & Leaf 1995; Baum et al, 1992) . Oxidative stress is discussed as an important factor for HIV disease progression and the development of AIDS (Israel & Gougerot-Pocidalo, 1997 ; Baruchel & Wainberg, Figure 2 Daily intake of quercetin and antioxidant vitamins before and during supplementation of fruit juices or fruit -vegetable-concentrate in HIVinfected and healthy subjects. Data presented as means AE s.e.m. Group J, subjects receiving 1 l of fruit-juice per day; group C, subjects receiving 30 ml fruitvegetable-concentrate per day; HIV þ , HIV-infected subjects, HIV 0 , HIV-seronegative subjects; w0, baseline; w16, 16th week of polyphenol supplementation. P-values given for difference between baseline and week 16 of intervention. Values within the filled bars refer to dietary intake (foodstuff and juices=concentrate) of the antioxidants. Values given outside the bars refer to the total antioxidant intake including vitamin preparations. Among the healthy subjects only one person in group J reported vitamin E supplementation.
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BM Arendt et al 1992). We investigated prospectively the influence of polyphenol supplementation on the plasma antioxidant capacity in HIV-seropositive subjects and compared the effects with seronegative controls. The polyphenols were administered via fruit juices or a fruit -vegetable-concentrate over 16 weeks in addition to the normal diet. There was no difference in plasma antioxidant capacity between HIV-infected and healthy subjects at baseline. After 16 weeks of intervention TEAC increased in HIVpositive subjects with both kinds of supplementation. In HIV patients supplemented with juice, the effect was still detectable after 6 weeks washout. In contrast, TEAC was not altered by either type of supplementation in the HIVseronegative subjects. We conclude that plasma antioxidant capacity can be increased by long-term ingestion of polyphenols from fruit juices or fruit -vegetable-concentrate in HIV-seropositive but not in HIV-seronegative subjects.
In contrast to the findings from other studies (Jareno et al, 1998; McLemore et al, 1998) , the HIV-seropositive subjects in our long-term study did not show decreased plasma antioxidant capacity compared to the healthy controls at baseline. The mean TEAC before intervention was 1.39 AE 0.07 mM for the HIV-infected patients, which is higher than reported by McLemore et al (1998) (1.04 AE 0.13 mM). This could be explained by the high percentage of persons using vitamins and other antioxidant supplements in our HIV-seropositive collective (Skurnick et al, 1996) .
For both, fruit juice and concentrate, the plasma antioxidant capacity increased in HIV-infected subjects after 16 weeks of supplementation. Although polyphenol concentration in plasma was not assessed, this effect might be attributed to phenolic compounds absorbed from fruit juices or concentrate as the kinetics of plasma TEAC after a single bolus dose of both beverages in healthy subjects corresponded to the absorption-and disposition kinetics of polyphenols reported by other authors (Lee et al, 1995; Manach et al, 1995) .
In contrast to the HIV-infected patients, no changes of plasma TEAC were observed in healthy subjects in either of the intervention groups. This different response to polyphenol supplementation cannot be explained by a depleted antioxidant status in HIV-infected patients as there was no difference between the baseline TEAC levels in both groups. Plasma antioxidant capacity was not correlated with viral load. Therefore changes of antiretroviral medication that decrease viral load and subsequently might reduce the production of free radicals neither seem to be the reason for the increased plasma TEAC in the HIV-infected group after 16 weeks of polyphenol supplementation.
Since smokers suffer from increased oxidative stress (Allard et al, 1994; Liu et al, 1998) , the higher percentage of smokers among HIV-infected patients (50 vs 20% among healthy subjects) might be a possible explanation for the detectable increase of plasma antioxidant capacity in the HIV-seropositive group. Figure 3 shows that in general the change in TEAC was more pronounced in smokers than in non-smokers. However, a significant rise occurred only in HIV-infected smokers after 16 weeks of intervention. Due to the small number of subjects it was not possible to distinguish clearly between the influence of HIV-infection and smoking on the response to polyphenol supplementation, leaving this important issue open to be addressed in future studies. However, as both factors cause oxidative stress, an increased plasma antioxidant capacity is probably favorable to HIVinfected patients as well as to smokers.
When interpreting the data we allowed for the different composition of the HIV-infected and the control group according to sex and antioxidant supplementation. As there was no difference between the plasma TEAC in healthy women and men at baseline, this factor is unlikely to have affected the results. Our observation that the HIVseropositive group with a high proportion of subjects using antioxidants showed a higher response to additional polyphenol supplementation than the healthy group without further supplementation seems contradictory. A higher turnover of antioxidants in HIV-infected patientsinduced by the infection or by smoking -or synergistic effects of polyphenols and antioxidant vitamins might be an approach to interpretation of our data.
Despite the few limitations discussed above, this preliminary study suggests that polyphenols from fruit juices or a fruit -vegetable-concentrate lead to an increase of plasma antioxidant capacity in subjects suffering from increased oxidative stress induced by HIV-infection. Therapeutic consequences and clinical implications for HIV-infected patients need to be further elucidated.
